Structural and In Vitro Functional Analyses of Novel Plant-Produced Anti-Human PD1 Antibody
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural and In Vitro Functional Analyses of Novel Plant-Produced Anti-Human PD1 Antibody
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-23
DOI
10.1038/s41598-019-51656-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in Nicotiana benthamiana Plants
- (2019) Vally Kommineni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A simplified techno‐economic model for the molecular pharming of antibodies
- (2019) Pere Mir‐Artigues et al. BIOTECHNOLOGY AND BIOENGINEERING
- Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults
- (2019) Stéphane Pillet et al. PLoS One
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity
- (2018) Huafang Lai et al. VACCINE
- Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults
- (2018) Jessica A. Chichester et al. VACCINE
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum‐Containing Chemotherapy
- (2017) Yang‐Min Ning et al. ONCOLOGIST
- FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma
- (2017) Yvette L. Kasamon et al. ONCOLOGIST
- Rapid Transient Production of a Monoclonal Antibody Neutralizing the Porcine Epidemic Diarrhea Virus (PEDV) in Nicotiana benthamiana and Lactuca sativa
- (2017) Kaewta Rattanapisit et al. PLANTA MEDICA
- Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: Recent insights and future challenges
- (2016) Francesca Tartari et al. CANCER TREATMENT REVIEWS
- Plant protein glycosylation
- (2016) Richard Strasser GLYCOBIOLOGY
- Techno-economic analysis of a transient plant-based platform for monoclonal antibody production
- (2016) Somen Nandi et al. mAbs
- Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3
- (2016) Tsepo Lebiletsa Tsekoa et al. PLoS One
- Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants
- (2015) Julian K-C. Ma et al. PLANT BIOTECHNOLOGY JOURNAL
- Plant Molecular Pharming for the Treatment of Chronic and Infectious Diseases
- (2014) Eva Stoger et al. Annual Review of Plant Biology
- Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy
- (2014) A. Hiatt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines
- (2014) Brian J. Ward et al. VACCINE
- Predictive models for transient protein expression in tobacco (Nicotiana tabacum L.) can optimize process time, yield, and downstream costs
- (2012) J.F. Buyel et al. BIOTECHNOLOGY AND BIOENGINEERING
- High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans
- (2011) A. M. Goetze et al. GLYCOBIOLOGY
- High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system
- (2010) Zhong Huang et al. BIOTECHNOLOGY AND BIOENGINEERING
- The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza
- (2010) Marc-André D’Aoust et al. PLANT BIOTECHNOLOGY JOURNAL
- Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure
- (2008) Richard Strasser et al. PLANT BIOTECHNOLOGY JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search